Cross Country Healthcare (CCRN) Tops Q3 EPS by 2c, Offers Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $315.12 million versus the consensus estimate of $310.22 million.

GUIDANCE:

Cross Country Healthcare sees Q4 2024 EPS of $0.10-$0.14, versus the consensus of $0.13. Cross Country Healthcare sees Q4 2024 revenue of $300-310 million, versus the consensus of $319 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• NeuroSense posts narrower H1 loss, targets Canada drug filing by December
• Northrop Grumman wins $143M in new U.S. defense contracts